Dr. Anna G. Strumba

Kelly Walkovich is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Walkovich is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Infantile Neutropenia, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Susan J. Woolford, MD, MPH, is an Assistant Professor in the Child Health Evaluation and Research (CHEAR) unit in the Division of General Pediatrics and the Medical Director of the C. S. Mott Children’s Hospital Pediatric Comprehensive Weight Management Center at the University of Michigan. Dr. Woolford earned her medical degree at Michigan State University where she also completed her residency and Chief Residency. She completed her Pediatric Health Services Research Fellowship at the University of Michigan, where she also received her Master of Public Health degree with an emphasis in Health Behavior and Health Education. Her clinical interests are childhood obesity prevention and treatment, particularly for severely obese adolescents.In recognition of her innovative work in the area of childhood obesity, Dr. Woolford has received awards from the American Academy of Pediatrics and from the Society for Adolescent Medicine.Dr. Woolford is pro-vaccine. Learn more about our vaccine policy. Our pediatricians provide evidence-based care for families. We are pro-vaccine and follow the AAP guidelines regarding the immunization schedule. Dr. Woolford is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Obesity in Children.

Dr. Steven Pipe is a Professor and the Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology at the University of Michigan, Ann Arbor, Michigan, USA. He is the medical director of the Pediatric Hemophilia and Coagulation Disorders Program and medical director of the Special Coagulation Laboratory. His clinical interests include bleeding and thrombotic disorders and congenital vascular anomalies. Dr Pipe also directs a basic research lab investigating coagulation factor VIII and the molecular mechanisms of hemophilia A. He has been actively involved in clinical trials with novel therapeutics for hemophilia including gene therapy. He was the 2015 recipient of the Leadership in Research Award from the National Hemophilia Foundation. He has served on the Board of Directors for the Hemostasis and Thrombosis Research Society, as Chair of the Board of Directors for the American Thrombosis and Hemostasis Network and currently as Chair of the Medical and Scientific Advisory Committee to the National Hemophilia Foundation. Dr. Pipe is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilia B, Blood Clots, and Von Willebrand Disease (VWD).